Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
British Journal of Cancer
|
January 8, 2009
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials
J P Neoptolemos, D D Stocken, C Tudur Smith, et al.
Langenbeck'S Archives of Surgery
|
November 22, 2019
The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis
A R G Sheel, R D Baron, L D Dickerson, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
July 14, 2004
Hereditary pancreatic endocrine tumours
N Alexakis, S Connor, P Ghaneh, et al.
Surgery
|
September 7, 2004
Influence of opioid use on surgical and long-term outcome after resection for chronic pancreatitis
N Alexakis, S Connor, P Ghaneh, et al.
World Journal of Surgery
|
March 1, 2019
Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging
L D Dickerson, A Farooq, F Bano, et al.
Digestive Surgery
|
November 19, 2005
Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial
C Bassi, D D Stocken, A Olah, et al.
Endocrine-Related Cancer
|
January 10, 2004
Surgery for midgut carcinoid
R Sutton, H E Doran, E M I Williams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Adjuvant therapy in pancreatic cancer: historical and current perspectives
J P Neoptolemos, D Cunningham, H Friess, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
GATA6 immunohistochemistry and prognosis after surgical resection of pancreatic adenocarcinoma: results from the ESPAC-4 trial
R C Grant, K Duan, R Jackson, et al.
Cancer Chemotherapy and Pharmacology
|
June 13, 2013
Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study
R P Jones, P Sutton, R M D Greensmith, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
British Journal of Cancer
|
January 8, 2009
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials
J P Neoptolemos, D D Stocken, C Tudur Smith, et al.
Langenbeck'S Archives of Surgery
|
November 22, 2019
The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis
A R G Sheel, R D Baron, L D Dickerson, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
July 14, 2004
Hereditary pancreatic endocrine tumours
N Alexakis, S Connor, P Ghaneh, et al.
Surgery
|
September 7, 2004
Influence of opioid use on surgical and long-term outcome after resection for chronic pancreatitis
N Alexakis, S Connor, P Ghaneh, et al.
World Journal of Surgery
|
March 1, 2019
Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging
L D Dickerson, A Farooq, F Bano, et al.
Digestive Surgery
|
November 19, 2005
Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial
C Bassi, D D Stocken, A Olah, et al.
Endocrine-Related Cancer
|
January 10, 2004
Surgery for midgut carcinoid
R Sutton, H E Doran, E M I Williams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Adjuvant therapy in pancreatic cancer: historical and current perspectives
J P Neoptolemos, D Cunningham, H Friess, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
GATA6 immunohistochemistry and prognosis after surgical resection of pancreatic adenocarcinoma: results from the ESPAC-4 trial
R C Grant, K Duan, R Jackson, et al.
Cancer Chemotherapy and Pharmacology
|
June 13, 2013
Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study
R P Jones, P Sutton, R M D Greensmith, et al.
Page
of 8